Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Endoscopy Market Size & Growth Forecast 2027–2036, By Segments (Product, Application, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 7585| Published Date: Jul-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Endoscopy Market size was estimated at USD 32.11 Billion in 2026 and is projected to grow at 7.53% CAGR from 2027 to 2036, crossing USD 66.36 Billion by 2036. The industry revenue for 2027 is assessed at USD 34.16 Billion.

Base Year Value (2025)
USD 44.23 Billion
CAGR (2026-2035)
6.9%
Forecast Year Value (2035)
USD 86.2 Billion
Historical Data Period
2021-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Endoscopy Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising gastrointestinal and cancer incidence driving demand for diagnostic endoscopic procedures

The growing burden of gastrointestinal disorders and various forms of cancer is increasing the need for early diagnosis and timely clinical intervention across healthcare systems. This trend will drive the endoscopy market growth as physicians increasingly rely on endoscopic procedures to detect abnormalities, obtain tissue samples, and monitor disease progression with greater precision. Expanding screening initiatives and the emphasis on early disease identification have also encouraged healthcare providers to strengthen their endoscopic diagnostic capabilities across hospitals and specialized care centers.

Growing preference for minimally invasive surgeries accelerating advanced endoscope adoption

Patients and healthcare providers are increasingly favoring minimally invasive procedures because they are associated with reduced surgical trauma, shorter recovery periods, and lower risk of postoperative complications. The endoscopy market benefits from this shift as advanced endoscopic systems enable surgeons to perform complex procedures through small incisions while maintaining enhanced visualization and procedural control. The broader adoption of minimally invasive treatment approaches has encouraged healthcare facilities to invest in technologically advanced endoscopic equipment across multiple clinical specialties.

Technological integration of high-definition imaging and robotics improving procedural accuracy

Continuous innovation in medical imaging and robotic-assisted technologies has significantly enhanced the capabilities of modern endoscopic systems. These advancements will propel the endoscopy market growth by providing clinicians with clearer visualization, improved instrument maneuverability, and greater precision during both diagnostic and therapeutic procedures. Enhanced image quality and sophisticated navigation features also support more accurate lesion identification and facilitate complex interventions in challenging anatomical locations.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising gastrointestinal and cancer incidence driving demand for diagnostic endoscopic procedures 2.2% High North America, Europe High Near Term
Growing preference for minimally invasive surgeries accelerating advanced endoscope adoption 2% High Europe, Asia Pacific High Near Term
Technological integration of high-definition imaging and robotics improving procedural accuracy 1.6% Moderate North America, Asia Pacific Medium Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
38.12% Market Share in 2026

North America (Largest Region)

In the endoscopy market, North America held the largest share of 38.12% in 2026, reflecting its advanced healthcare infrastructure, strong adoption of minimally invasive procedures, and established diagnostic capabilities. The region benefits from broad access to sophisticated medical technologies and a well-developed network of hospitals and specialized care facilities. Increasing preference for minimally invasive diagnosis and treatment is encouraging the use of advanced endoscopic systems, while ongoing healthcare investment and emphasis on early disease detection continue to support regional demand.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is projected to experience the fastest growth, supported by expanding healthcare infrastructure, rising healthcare expenditure, and improving access to advanced diagnostic procedures. Growing awareness of minimally invasive treatment options is encouraging greater adoption of endoscopic technologies across both established and emerging healthcare systems. The expansion of hospitals and specialty care facilities, combined with efforts to improve diagnostic capacity, is creating favorable conditions for wider use of endoscopy equipment and procedures throughout the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

United States 🇺🇸

Minimally Invasive Expansion

The U.S. endoscopy market is driven by growing adoption of minimally invasive diagnostic and therapeutic procedures across hospitals and ambulatory care settings. Healthcare providers in the U.S. continue investing in advanced visualization systems and workflow-enhancing endoscopic technologies.

Germany 🇩🇪

Precision Imaging Adoption

Germany prioritizes high-performance endoscopy systems that improve diagnostic accuracy and procedural efficiency in clinical practice. Healthcare facilities in Germany increasingly integrate digital imaging, enhanced visualization, and specialized endoscopic equipment into routine care pathways.

Japan 🇯🇵

Advanced Clinical Visualization

Japan advances the endoscopy market through continuous refinement of imaging technologies and widespread clinical use of minimally invasive procedures. Medical institutions in Japan emphasize high-definition visualization, precision diagnostics, and efficient patient management across multiple specialties.

South Korea 🇰🇷

Smart Procedure Integration

South Korea supports endoscopy adoption through digitally connected healthcare environments and growing demand for minimally invasive interventions. Hospitals in South Korea increasingly implement advanced endoscopic platforms that enhance procedural efficiency and clinical decision-making.

France 🇫🇷

Preventive Diagnostic Focus

France encourages broader use of endoscopy within preventive healthcare and early disease detection initiatives. Healthcare providers in France continue upgrading endoscopic equipment to improve image quality, patient comfort, and procedural effectiveness across clinical settings.

Italy 🇮🇹

Hospital Equipment Renewal

Italy strengthens the endoscopy market through ongoing replacement of clinical equipment and expanded access to minimally invasive procedures. Medical centers in Italy prioritize reliable endoscopic platforms that support efficient diagnostics, therapeutic interventions, and streamlined clinical workflows.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Endoscopy Market Share (%), End Use, 2025

Hospitals
Ambulatory Surgical Centers
Other End Use

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Product Segment Analysis: Endoscopes (Largest Segment) vs Visualization Systems (Fastest-Growing Segment)

The endoscopes product segment dominated the endoscopy market, accounting for 52.15% of the market share in 2026. Endoscopes serve as the core instruments for minimally invasive diagnostic and therapeutic procedures across numerous medical specialties, making them indispensable in routine clinical practice. Continuous technological improvements in flexibility, image quality, and maneuverability, together with the growing preference for minimally invasive interventions, continue to strengthen demand for endoscopes across healthcare facilities.

The visualization systems product segment is experiencing the fastest growth as healthcare providers increasingly invest in advanced imaging technologies that improve procedural accuracy and clinical decision-making. High-definition displays, enhanced image processing capabilities, and digital visualization platforms enable clinicians to achieve greater precision during complex procedures while improving workflow efficiency. Ongoing advancements in imaging technology and increasing adoption of integrated operating room solutions are supporting rapid expansion of this segment.

Application Segment Analysis: Laparoscopy (Largest Segment) vs GI Endoscopy (Fastest-Growing Segment)

Holding the largest share of the endoscopy market, the laparoscopy application segment accounted for 20.13% in 2026. Its leading position is supported by the widespread adoption of minimally invasive surgical procedures for abdominal and pelvic conditions, where laparoscopy offers reduced patient trauma, shorter hospital stays, and faster postoperative recovery. Increasing surgeon preference for minimally invasive techniques and continual improvements in laparoscopic equipment continue to reinforce the segment's dominance.

The gastrointestinal (GI) endoscopy application segment is witnessing the fastest growth as the prevalence of digestive disorders and the emphasis on early disease detection continue to increase worldwide. GI endoscopy plays a vital role in diagnosing, monitoring, and treating a broad range of gastrointestinal conditions while supporting preventive screening programs. Rising awareness of digestive health and expanding access to advanced diagnostic services are contributing to the segment's accelerating adoption.

End Use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

The hospitals end-use segment held the largest position in 2026, supported by the availability of comprehensive medical infrastructure, specialized healthcare professionals, and advanced endoscopic equipment required for complex diagnostic and therapeutic procedures. Hospitals perform a high volume of endoscopic interventions across multiple specialties, making them the primary setting for the adoption of sophisticated endoscopy technologies.

The ambulatory surgical centers end-use segment is emerging as the fastest-growing segment in the endoscopy market due to the increasing preference for cost-effective outpatient procedures and shorter patient recovery times. These facilities are expanding their capabilities by adopting advanced endoscopic technologies that enable efficient minimally invasive interventions while reducing hospital burden. Growing demand for convenient healthcare delivery and improved procedural efficiency continues to support the rapid growth of this segment.

Segment Sub-Segment Largest Segment Fastest Growing
Product Endoscopes, Visualization Systems, Endoscopic Ultrasound, Insufflator, Other Products
Application Laparoscopy, GI Endoscopy, Arthroscopy, ENT Endoscopy, Pulmonary Endoscopy, Obstetrics/Gynecology, Other Applications
End Use Hospitals, Ambulatory Surgical Centers, Other End Use
Competitive Landscape

Competitive Landscape and Market Positioning

Major players in the endoscopy market:

  1. Olympus Corporation (Japan)
  2. Karl Storz SE & Co. KG (Germany)
  3. Medtronic plc (Ireland)
  4. Boston Scientific Corporation (United States)
  5. Fujifilm Holdings Corporation (Japan)
  6. Johnson & Johnson (United States)
  7. Stryker Corporation (United States)
  8. B. Braun Melsungen AG (Germany)
  9. CONMED Corporation (United States)
  10. Intuitive Surgical, Inc. (United States)

Innovation cycles have accelerated across the endoscopy market as healthcare providers seek technologies that improve procedural precision while enhancing clinical workflow and patient outcomes. Competitive advantage is increasingly linked to the ability to combine imaging quality, device ergonomics, software integration, and minimally invasive capabilities into comprehensive procedural platforms rather than offering standalone instruments. Growing demand for earlier disease detection is encouraging continuous refinement of visualization technologies, artificial intelligence-assisted image interpretation, and disposable or hybrid device designs that address infection control concerns without compromising clinical performance. Service capabilities, clinician training, and compatibility with existing hospital infrastructure have also become meaningful differentiators, particularly as healthcare facilities place greater emphasis on operational efficiency and long-term equipment utilization.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Fujifilm Jun-26 Fujifilm expanded its logistics and service infrastructure in the endoscopy market by opening an 18,000-square-foot warehouse facility in New Jersey. This strategic investment strengthens the company's supply chain and operational capabilities, ensuring enhanced support for its growing installed base of endoscopy systems and facilitating efficient service delivery across the region.
Folsom Sierra Endoscopy Center Mar-26 Folsom Sierra Endoscopy Center initiated a $14 million expansion project to construct a new gastrointestinal surgery facility. This major capital investment is set to substantially increase the center's procedural throughput, upgrade its operational infrastructure, and strengthen its regional capacity to meet the growing demand for specialized endoscopic and gastrointestinal surgical interventions.
Borland Groover Mar-26 Borland Groover began construction on the Emerald Coast Endoscopy Center in Santa Rosa Beach, a strategic expansion designed to broaden its regional service network. The development of this dedicated facility reflects a deliberate move to increase access to specialized digestive healthcare services and improve regional care delivery through localized infrastructure investment.
Carle Health Mar-26 Carle Health partnered with Christie Clinic to establish the Champaign Endoscopy Center. This collaborative facility expansion focuses on increasing regional access to digestive healthcare, specifically by providing a dedicated environment for high-volume procedures including colonoscopy and upper endoscopy, thereby enhancing the operational footprint for clinical services in the region.
Intermountain Health Mar-26 Intermountain Health opened a new Gastroenterology Center in Ogden featuring a dedicated ambulatory endoscopy suite. The facility is designed to optimize the delivery of gastroenterology procedures, including colonoscopy screenings, by focusing on enhancing procedural efficiency, improving patient access, and reducing costs through a more scalable and specialized care model.
CG MedTech Dec-25 CG MedTech acquired a 90% stake in Germany-based Solendos, securing an FDA-cleared endoscopy platform. This acquisition is strategically designed to bolster the company's spine endoscopy portfolio and extend its specialized capabilities in minimally invasive spinal procedures, marking a significant expansion of its clinical footprint and competitive positioning within the endoscopy device sector.
Olympus Corporation Sep-25 Olympus commercially launched its OLYSENSE CAD/AI portfolio across the United States and Europe, advancing the integration of artificial intelligence in clinical practice. The deployment provides AI-assisted computer-aided detection capabilities, representing a significant shift in technology adoption that enhances diagnostic accuracy and procedural efficiency within endoscopic workflows, thereby strengthening the company's position in the digital endoscopy segment.
MedInTech May-24 MedInTech secured 20 billion won (approximately $14.6 million) in Series B funding to accelerate the research, development, and commercialization of its smart endoscopy technologies. This capital infusion supports the scaling of its next-generation platform, strengthening the company's operational capacity and long-term ability to compete in the rapidly evolving market for AI-integrated and smart diagnostic medical devices.
Ambu Apr-24 Ambu secured FDA 510(k) clearance for its next-generation aScope Duodeno 2 and aBox 2, specifically designed for endoscopic retrograde cholangiopancreatography (ERCP) procedures. This regulatory milestone enables the commercialization of an advanced, single-use duodenoscopy solution, significantly expanding Ambu’s portfolio, broadening its addressable customer base, and enhancing its competitive standing in the endoscopy market.
Canon Medical Systems Jan-24 Canon Medical Systems and Olympus established a strategic collaboration to jointly develop and commercialize a next-generation endoscopic ultrasound system. By integrating Canon’s diagnostic imaging expertise with Olympus’s endoscopy technology, the partnership aims to accelerate innovation, enhance clinical diagnostic precision, and strengthen the market presence of both companies in advanced endoscopic imaging.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Endoscopy Market — Custom Segments

Segment Sub-Segment
No segment data available.

Endoscopy Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

How big is the endoscopy market?

The market revenue for endoscopy is anticipated at USD 34.16 Billion in 2027.

How is the endoscopy industry expected to grow over the next 10 years?

Endoscopy Market size was estimated at USD 32.11 Billion in 2026 and is projected to grow at 7.53% CAGR from 2027 to 2036, crossing USD 66.36 Billion by 2036.

How is the preference for minimally invasive procedures influencing the endoscopy market?

Healthcare providers are investing in advanced endoscopic systems that support minimally invasive procedures with enhanced visualization and procedural control. This shift improves treatment capabilities while reducing surgical trauma and recovery time.

What role is technology playing in advancing the endoscopy market?

Integration of high-definition imaging and robotic-assisted technologies improves visualization, instrument maneuverability, and procedural precision. These innovations enable more accurate diagnosis and support complex therapeutic interventions.

Why are endoscopes the largest product segment in the endoscopy market?

Endoscopes accounted for 52.15% of the market in 2026 because they are essential for minimally invasive diagnostic and therapeutic procedures, supported by ongoing improvements in image quality, flexibility, and maneuverability.

Which application segment is expected to grow the fastest in the endoscopy market?

GI endoscopy is projected to grow the fastest as increasing digestive disorders, greater emphasis on early disease detection, and expanding preventive screening programs drive higher adoption of advanced endoscopic procedures.

What makes North America the leading region in the endoscopy market?

North America held a 38.12% share in 2026, supported by advanced healthcare infrastructure, strong minimally invasive procedure adoption, and established diagnostic capabilities.

Why is Asia Pacific expected to see rapid growth in endoscopy?

Asia Pacific is projected to grow fastest as healthcare infrastructure, spending, hospital capacity, and access to advanced minimally invasive diagnostic procedures expand.

Who are the major participants shaping the endoscopy landscape?

Top companies in the endoscopy market include Olympus Corporation (Japan), Karl Storz SE & Co. KG (Germany), Medtronic plc (Ireland), Boston Scientific Corporation (United States), Fujifilm Holdings Corporation (Japan), Johnson & Johnson (United States), Stryker Corporation (United States), B. Braun Melsungen AG (Germany), CONMED Corporation (United States), Intuitive Surgical, Inc. (United States)
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →